Measures activity, not value. Not investment advice.
Reported $17.6B in 511 companies we cover at the end of Q3 2026; opened 101 positions and sold out of 88; largest new position: UroGen Pharma, $91.7M.
Reported value, Q3 2026 iThe total market value the manager reported on Form 13F for the quarter end, in dollars, including companies outside our coverage. 13F lists long positions in US-listed shares and options only, and is filed up to 45 days after the quarter ends.
$17.6B
Positions in companies we cover
511
Their share of the reported value
97%
Report filed
10 Nov 2026
Reported value per quarter, Q4 2016 to Q3 2026
Q4 2016Highest $20.5BQ3 2026
Every quarter
Quarter
Reported value
Positions we cover
Filed
Report
Q3 2026
$17.6B
511
10 Nov 2026
13F-HR
Q2 2026
$20.5B
498
13 Aug 2026
13F-HR
Q1 2026
$16.4B
480
11 May 2026
13F-HR
Q4 2025
$16.6B
527
11 Feb 2026
13F-HR
Q3 2025
$18.5B
480
6 Nov 2025
13F-HR
Q2 2025
$16.4B
441
6 Aug 2025
13F-HR
Q1 2025
$14.4B
446
9 May 2025
13F-HR
Q4 2024
$14.8B
522
3 Feb 2025
13F-HR
Q3 2024
$17.2B
489
6 Nov 2024
13F-HR
Q2 2024
$16.9B
475
13 Aug 2024
13F-HR
Q1 2024
$14.6B
503
10 May 2024
13F-HR
Q4 2023
$12.4B
492
8 Feb 2024
13F-HR
Q3 2023
$11.3B
555
27 Oct 2023
13F-HR
Q2 2023
$13.1B
456
7 Aug 2023
13F-HR
Q1 2023
$10.3B
581
9 May 2023
13F-HR
Q4 2022
$10.0B
449
13 Feb 2023
13F-HR
Q3 2022
$6.0B
355
14 Nov 2022
13F-HR
Q2 2022
$8.6B
473
8 Aug 2022
13F-HR
Q1 2022
$9.9B
468
13 May 2022
13F-HR
Q4 2021
$11.2B
530
11 Feb 2022
13F-HR
Q3 2021
$7.8B
513
2 Nov 2021
13F-HR
Q2 2021
$6.3B
474
13 Aug 2021
13F-HR
Q1 2021
$4.8B
433
12 May 2021
13F-HR
Q4 2020
$4.5B
463
11 Feb 2021
13F-HR
Q3 2020
$2.4B
405
12 Nov 2020
13F-HR
Q2 2020
$2.3B
241
13 Aug 2020
13F-HR
Q1 2020
$2.3B
312
6 May 2020
13F-HR
Q4 2019
$3.3B
378
10 Feb 2020
13F-HR
Q3 2019
$3.9B
375
8 Nov 2019
13F-HR
Q2 2019
$5.7B
566
12 Aug 2019
13F-HR
Q1 2019
$4.6B
522
13 May 2019
13F-HR
Q4 2018
$4.6B
508
13 Feb 2019
13F-HR
Q3 2018
$5.8B
561
6 Nov 2018
13F-HR
Q2 2018
$5.2B
494
10 Aug 2018
13F-HR
Q1 2018
$5.5B
515
7 May 2018
13F-HR
Q4 2017
$6.0B
514
6 Feb 2018
13F-HR
Q3 2017
$5.2B
542
8 Nov 2017
13F-HR
Q2 2017
$5.2B
544
25 Jul 2017
13F-HR
Q1 2017
$5.5B
366
1 May 2017
13F-HR
Q4 2016
$5.3B
350
6 Feb 2017
13F-HR
Q3 2016
$8.3B
362
14 Nov 2016
13F-HR
Q2 2016
$7.4B
334
27 Jul 2016
13F-HR
Q1 2016
$8.0B
317
12 May 2016
13F-HR
Q4 2015
$16.6B
392
12 Feb 2016
13F-HR
Q3 2015
$14.5B
321
10 Nov 2015amended 9 Dec 2015
13F-HR/A
Q2 2015
$18.5B
359
10 Aug 2015
13F-HR
Q1 2015
$19.9B
448
14 May 2015
13F-HR
Q4 2014
$21.2B
436
17 Feb 2015
13F-HR
Q3 2014
$17.2B
368
14 Nov 2014
13F-HR
Q2 2014
$19.8B
377
14 Aug 2014
13F-HR
Q1 2014
$18.9B
388
14 May 2014
13F-HR
Q4 2013
$19.9B
394
14 Feb 2014
13F-HR
Q3 2013
$18.4B
345
13 Nov 2013
13F-HR
Q2 2013
$18.9B
350
14 Aug 2013
13F-HR
Holdings at the end of Q3 2026
Largest 50 of 511, by value
#
Company
Shares
Value
% of portfolio iThe position's value as a share of the reported value of the whole report.
% of company iShares held as a share of the company's shares outstanding (latest financial report).
Share of the value in companies we cover, Q3 2026 against Q2 2026
Sector
Q3 2026
As a bar
Q2 2026
Change
Technology
52%
54%
-1.9 pts
Health Care
7.9%
6.6%
+1.3 pts
Retail
7.2%
6.1%
+1.2 pts
Manufacturing
4.7%
3.9%
+0.8 pts
Services
3.7%
4.8%
-1.0 pts
Transportation
3.1%
2.8%
+0.2 pts
Energy
2.9%
1.7%
+1.2 pts
Financials
2.6%
3.1%
-0.5 pts
Utilities
2.4%
2.7%
-0.3 pts
Materials
2.2%
2.9%
-0.7 pts
Communication Services
1.9%
0.94%
+0.9 pts
Aerospace & Defense
1.8%
2.6%
-0.9 pts
Consumer Staples
1.8%
2.0%
-0.3 pts
Automotive
1.7%
2.1%
-0.4 pts
Wholesale Trade
0.95%
1.1%
-0.2 pts
Not classified
0.79%
0.84%
-0.1 pts
Real Estate
0.67%
0.43%
+0.2 pts
Mining
0.62%
0.36%
+0.3 pts
Construction
0.39%
0.46%
-0.1 pts
Agriculture, Forestry & Fishing
0.04%
0.01%
0 pts
Consumer Discretionary
0.01%
0.00%
0 pts
The bar is Q3 2026; the tick marks Q2 2026.
From Form 13F: long positions in US-listed shares and options at the quarter end, filed up to 45 days later; short positions are not reported. Values are in dollars (reports filed before 2023 were in thousands and are converted). Measures activity, not value. Not investment advice.